USPTO serial 79296387
NADAL
Reviewed by CopyMark Law Group
Status 603
- Filing date
- Status date
- Registration date
- —
- Examiner
- SETTLES LEWIS, SHAILA E
- Law office
- TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NADAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic and analysis agents, preparations and reagents for medical and veterinary purposes, namely, for testing of allergies, autoimmunity diseases, presence of bacteria, diabetes, blood glucose levels, inflammation, fertility or infertility, pregnancy, sexually transmitted diseases, urinary tract infections, cancer, hormonal disorders, immune status, presence of fungi, presence of viral markers, infectious diseases, food intolerances, kidney dysfunction, liver dysfunction, thyroid gland dysfunction, cardiovascular dysfunction, or metabolic dysfunction; test strips for medical and veterinary purposes for testing the presence of allergies, autoimmunity markers, bacteria, fungi, viral markers, diabetes markers, inflammation markers, fertility hormones, pregnancy hormones, fertility markers, markers for sexually transmitted diseases, markers for urinary tract infections, markers for infectious diseases, endocrinology markers, metabolic markers, tumor markers, hormones, blood markers, markers for food intolerances, markers for kidney dysfunction, markers for liver dysfunction, markers for thyroid gland dysfunction, markers for cardiovascular dysfunction or markers for metabolic dysfunction, for testing immune status, urine, or blood glucose levels; immunological quick tests for instant diagnostics; medical diagnostic preparations, in particular diagnostic quick tests, for use in the fields of infectology, pediatrics, gynecology, bacteriology, urology, latex agglutination, cardiology, oncology and drug analysis; reagents for use in diagnostic pregnancy tests; reagents for use in ovulation tests for medical purposes; reagents for use in diagnostic HIV tests; reagents for use in drug tests for medical purposes; myocardial infarction markers; diagnostic agents and preparations in the nature of test stripes, test cassettes, multi-line tests, test liquids, ELISA tests, EIAs (enzyme immuno assays), or dry chemistry assay kits for detecting infectious diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 19, 2023 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 1, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 1, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 1, 2022 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| Jun 1, 2022 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| Jun 1, 2022 | ABN3 | ABANDONMENT - AFTER EX PARTE APPEAL | — |
| Jun 1, 2022 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Apr 19, 2022 | EXFB | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | — |
| Apr 17, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 27, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 23, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 1, 2022 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Feb 1, 2022 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Feb 1, 2022 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Jan 7, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 7, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 6, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jan 4, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 4, 2022 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jan 4, 2022 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jan 4, 2022 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 21, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 21, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 21, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 8, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 8, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 8, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 27, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 9, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 9, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 21, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 20, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 16, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 30, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 26, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 22, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |